Citi has revised its price target for Kenvue (KVUE, Financial), elevating it from $21 to $22, while maintaining a Neutral rating on the stock. This adjustment forms part of a broader Q1 earnings preview for the beverages and household and personal care sector. Analysts have pointed to a challenging setup for the industry in the upcoming quarter, citing subdued market commentary across the U.S., Europe, and emerging markets. Additionally, expectations for many companies lean towards the latter half of the year, compounded by tariff risks.
In its analysis, Citi expresses a preference for companies that demonstrate clear visibility on short-term trends and those offering unique opportunities. Within the sector, the firm has a favorable outlook on Keurig Dr Pepper (KDP), Boston Beer (SAM), and Church & Dwight (CHD). Conversely, it advises caution regarding Procter & Gamble (PG), Colgate-Palmolive (CL), and Coca-Cola (KO), indicating a more circumspect view of their near-term performance prospects. As the earnings season approaches, these insights are poised to guide investor expectations.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 14 analysts, the average target price for Kenvue Inc (KVUE, Financial) is $24.15 with a high estimate of $29.00 and a low estimate of $21.00. The average target implies an upside of 9.31% from the current price of $22.09. More detailed estimate data can be found on the Kenvue Inc (KVUE) Forecast page.
Based on the consensus recommendation from 19 brokerage firms, Kenvue Inc's (KVUE, Financial) average brokerage recommendation is currently 2.6, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
